Nicergoline


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 18.1%
Drug Use For Unknown Indication 16.4%
Acute Coronary Syndrome 10.3%
Pain 8.6%
Depression 4.3%
Anxiety 3.4%
Arrhythmia 3.4%
Insomnia 3.4%
Mental Impairment 3.4%
Prophylaxis 3.4%
Cardiovascular Event Prophylaxis 2.6%
Cerebral Circulatory Failure 2.6%
Epilepsy 2.6%
Gastritis Prophylaxis 2.6%
Herpes Zoster 2.6%
Hyperlipidaemia 2.6%
Hypertriglyceridaemia 2.6%
Product Used For Unknown Indication 2.6%
Stomatitis 2.6%
Abdominal Pain 1.7%
Drug Interaction 17.4%
Unevaluable Event 13.0%
Cerebral Haemorrhage 8.7%
Overdose 8.7%
Renal Failure 8.7%
Death 4.3%
Depressed Level Of Consciousness 4.3%
Loss Of Consciousness 4.3%
Rash Maculo-papular 4.3%
Respiratory Distress 4.3%
Rheumatoid Factor Positive 4.3%
Somnolence 4.3%
Surgery 4.3%
Thrombocytopenia 4.3%
Vomiting 4.3%
Concomitant
Hypertension 17.4%
Drug Use For Unknown Indication 17.0%
Cerebral Infarction 7.9%
Psoriasis 7.9%
Product Used For Unknown Indication 7.1%
Prophylaxis 5.3%
Myocardial Ischaemia 4.5%
Colorectal Cancer 3.2%
Hyperlipidaemia 3.2%
Constipation 3.0%
Back Pain 2.6%
Depression 2.6%
Insomnia 2.6%
Dementia 2.4%
Dementia Alzheimer's Type 2.4%
Hypercholesterolaemia 2.4%
Asthma 2.2%
Gastric Ulcer 2.2%
Osteoporosis 2.2%
Rhinitis Allergic 2.2%
Rhabdomyolysis 20.8%
Syncope 11.1%
Somnolence 6.9%
Drug Interaction 5.6%
Muscular Weakness 5.6%
Acute Myocardial Infarction 4.2%
Electrolyte Imbalance 4.2%
Laryngeal Oedema 4.2%
Pain 4.2%
Tumour Lysis Syndrome 4.2%
Urine Output Increased 4.2%
Altered State Of Consciousness 2.8%
Aortic Dissection Rupture 2.8%
Blood Urea Increased 2.8%
Fall 2.8%
General Physical Health Deterioration 2.8%
Haematuria 2.8%
Hypoglycaemia 2.8%
Hypoglycaemic Coma 2.8%
Injection Site Pain 2.8%

Drug Data